Active ingredientNintedanibCat. No. P-N069-001CAS 656247-17-5Family · Pharmaceutical analytical standards
Nintedanib
A multi-tyrosine kinase inhibitor approved in 2014 for idiopathic pulmonary fibrosis and, in Europe, also for some lung cancers. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?Born as a cancer medicine against blood-vessel growth, it found its main use in slowing lung fibrosis.
Go to the active ingredient →Active ingredientNintedanibCat. No. P-N069-001CAS 656247-17-5
Pharmacopoeial impurityMethyl (E)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylateCat. No. P-N069-002CAS 1168150-46-6
MetaboliteNintedanib Demethyl-O-GlucuronideCat. No. P-N069-004CAS 1352789-50-4
MetaboliteNintedanib N-Glucuronide-1Cat. No. P-N069-005
Isotopically labelledNintedanib Impurity 41-13C-d3Cat. No. P-N069-007
Isotopically labelledNintedanib-13C-d3Cat. No. P-N069-008
Isotopically labelledNintedanib-13C-d3 Demethyl-O-GlucuronideCat. No. P-N069-009
Isotopically labelledNintedanib-d8Cat. No. P-N069-010CAS 1624587-87-6
NitrosamineN-Nitroso NintedanibCat. No. P-N069-013
ImpurityNintedanib Impurity 1Cat. No. P-N069-016CAS 1168152-07-5
ImpurityNintedanib Impurity 2Cat. No. P-N069-017CAS 1160293-27-5
ImpurityN-Methyl-1,4-phenylenediamine DihydrochlorideCat. No. P-N069-018CAS 5395-70-0
ImpurityNintedanib dimerCat. No. P-N069-019CAS 2410284-89-6
ImpurityNintedanib Impurity 3Cat. No. P-N069-020CAS 78466-25-8
ImpurityNintedanib Impurity 4Cat. No. P-N069-021CAS 22323-80-4
ImpurityNintedanib Impurity 5Cat. No. P-N069-022CAS 2653-15-8
ImpurityNintedanib intermediateCat. No. P-N069-023CAS 2653-16-9
Impurity3-Amino-4-(carboxymethyl)benzoic acidCat. No. P-N069-024CAS 1373232-85-9
ImpurityNintedanib Impurity 6Cat. No. P-N069-025CAS 1253768-91-0
Impurity3-Nitrophenyloxycarbonyl chlorideCat. No. P-N069-026CAS 14235-05-3
Impurity4-(Carboxymethyl)-3-nitrobenzoic acidCat. No. P-N069-027CAS 444667-11-2
Impurity4-Chlorobenzaldehyde dimethyl acetalCat. No. P-N069-028CAS 3395-81-1
ImpurityNintedanib Impurity 7Cat. No. P-N069-029CAS 708279-23-6
ImpurityBenzaldehyde dimethyl acetalCat. No. P-N069-030CAS 1125-88-8
ImpurityDesmethyl nintedanibCat. No. P-N069-031CAS 894783-61-0
ImpurityNintedanib Impurity 8Cat. No. P-N069-032CAS 2765161-53-1
ImpurityDimethyl 2-Oxoindoline-3,6-dicarboxylateCat. No. P-N069-033CAS 2514952-69-1
ImpurityEthyl 2-oxoindoline-6-carboxylateCat. No. P-N069-034CAS 954239-49-7
ImpurityEthyl EthanesulfonateCat. No. P-N069-035CAS 1912-30-7
ImpurityMethyl 1-Acetyl-2-oxoindoline-6-carboxylateCat. No. P-N069-036CAS 676326-36-6
ImpurityNintedanib Impurity 9Cat. No. P-N069-037CAS 1895918-24-7
ImpurityNintedanib Impurity 10Cat. No. P-N069-038CAS 2036139-30-5
ImpurityMethyl 4-chloro-3-nitrobenzoateCat. No. P-N069-040CAS 14719-83-6
ImpurityMethyl ethanesulfonateCat. No. P-N069-041CAS 1912-28-3
ImpurityMethyl Oxindole-6-carboxylateCat. No. P-N069-042CAS 14192-26-8
ImpurityMethyl oxindole-7-carboxylateCat. No. P-N069-043CAS 380427-39-4
ImpurityN,N-Dimethyl-4-nitroanilineCat. No. P-N069-044CAS 100-23-2
ImpurityNintedanib Impurity 11Cat. No. P-N069-045CAS 2117628-65-4
ImpurityNintedanib Impurity 12Cat. No. P-N069-046CAS 855860-75-2
ImpurityNintedanib Impurity 13Cat. No. P-N069-047CAS 262368-30-9
ImpurityNintedanib Impurity 14Cat. No. P-N069-048CAS 2243384-71-4
ImpurityN-(4-aminophenyl)-N-methylacetamideCat. No. P-N069-049CAS 119-63-1
ImpurityN-Desmethyl NintedanibCat. No. P-N069-050CAS 334951-61-0
ImpurityNintedanib Impurity 15Cat. No. P-N069-051CAS 1038972-16-5
ImpurityN-methyl-N-(4-nitrophenyl)acetamideCat. No. P-N069-052CAS 121-95-9
ImpurityN-Propanoyl NintedanibCat. No. P-N069-053CAS 2097505-01-4
ImpurityNintedanib 4-Hydroxyphenyl AnalogCat. No. P-N069-054CAS 2519501-85-8
ImpurityNintedanib Acetamide ImpurityCat. No. P-N069-055CAS 262368-25-2
ImpurityNintedanib Acetyl ImpurityCat. No. P-N069-056CAS 1139458-48-2
ImpurityNintedanib carboxylic acidCat. No. P-N069-057CAS 894783-71-2
ImpurityNintedanib E-isomerCat. No. P-N069-058
Active ingredientNintedanib EsilateCat. No. P-N069-059CAS 656247-18-6
ImpurityNintedanib Impurity 16Cat. No. P-N069-060
ImpurityNintedanib Impurity 17Cat. No. P-N069-063CAS 1139455-52-9
ImpurityNintedanib Impurity 18Cat. No. P-N069-064
ImpurityNintedanib Impurity 19Cat. No. P-N069-065
ImpurityNintedanib Impurity 20Cat. No. P-N069-066
ImpurityNintedanib Impurity 21Cat. No. P-N069-067CAS 1168152-06-4
ImpurityNintedanib Impurity 22Cat. No. P-N069-068CAS 1027407-75-5
ImpurityNintedanib Impurity 23Cat. No. P-N069-069
ImpurityNintedanib Impurity 24Cat. No. P-N069-070
ImpurityNintedanib Impurity 25Cat. No. P-N069-071
ImpurityNintedanib Impurity 26Cat. No. P-N069-072
ImpurityNintedanib Impurity 27Cat. No. P-N069-073CAS 1174335-83-1
ImpurityNintedanib Impurity 28Cat. No. P-N069-074
ImpurityNintedanib Impurity 29Cat. No. P-N069-075
ImpurityNintedanib Impurity 30Cat. No. P-N069-076
ImpurityNintedanib Impurity 31Cat. No. P-N069-077
ImpurityNintedanib Impurity 32Cat. No. P-N069-078
ImpurityNintedanib Impurity 33Cat. No. P-N069-081CAS 2380229-45-6
ImpurityNintedanib Impurity 34Cat. No. P-N069-084CAS 1987887-92-2
ImpurityNintedanib Impurity 35Cat. No. P-N069-087CAS 2410284-90-9
ImpurityNintedanib Impurity 36Cat. No. P-N069-090CAS 2102162-79-6
ImpurityNintedanib Impurity 37Cat. No. P-N069-091CAS 2102162-78-5
ImpurityNintedanib Impurity 38Cat. No. P-N069-092CAS 2101947-36-6
ImpurityNintedanib Impurity 39Cat. No. P-N069-097
ImpurityNintedanib Impurity 40Cat. No. P-N069-098CAS 1610881-60-1
ImpurityDesmethyl Nintedanib Carboxylic AcidCat. No. P-N069-111
ImpurityNintedanib Impurity BCat. No. P-N069-112
ImpurityDesmethyl Nintedanib 7-Carboxylate IsomerCat. No. P-N069-113
ImpurityNintedanib Impurity FCat. No. P-N069-115
ImpurityNintedanib Methyl Impurity (Z Isomer)Cat. No. P-N069-117
ImpurityNintedanib N,N-DioxideCat. No. P-N069-118CAS 2734676-68-5
Impurityp-(Dimethoxymethyl)anisoleCat. No. P-N069-120CAS 2186-92-7
ImpurityS-Ethyl carbamothioateCat. No. P-N069-121CAS 637-98-9
ImpurityTrimethyl OrthobenzoateCat. No. P-N069-122CAS 707-07-3No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceNintedanib esilate CRSEDQM code Y0002577Family NintedanibImpurityNintedanib impurity C CRSEDQM code Y0002579Family NintedanibNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.